BIOMAT Database Logo BIOMAT Database Logo

[Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients]. 1986

T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002301 Cardiac Glycosides Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose. Cardiac Glycoside,Cardiotonic Steroid,Cardiotonic Steroids,Glycoside, Cardiac,Glycosides, Cardiac,Steroid, Cardiotonic,Steroids, Cardiotonic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
October 1983, Vrachebnoe delo,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Chorionic gonadotropin in the treatment of chronic circulatory failure in ischemic heart disease patients].
July 1984, Vrachebnoe delo,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Ambulatory treatment of chronic heart failure with peripheral vasodilators].
November 1984, Kardiologiia,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
September 1989, Vrachebnoe delo,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Peripheral vasodilators in the treatment of heart failure].
January 1989, Farmakologiia i toksikologiia,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Peripheral vasodilators in the treatment of heart failure].
January 1982, Pediatriia,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Differential use of peripheral vasodilators in the treatment of chronic circulatory failure in patients with mitral valve insufficiency].
March 1990, Kardiologiia,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Atrial natriuretic peptide in chronic circulatory failure in patients with ischemic heart disease].
September 1990, Vrachebnoe delo,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Role of peripheral vasodilators in the complex treatment of chronic pulmonary heart disease].
January 1986, Problemy tuberkuleza,
T N Lipnitskiĭ, and M G Sheverda, and Iu K Otkalenko, and A Kh Brovko, and E A Bogdanov
[Nebivolol in the treatment of ischemic heart disease patients with chronic heart failure].
January 2004, Kardiologiia,
Copied contents to your clipboard!